Year: 2017
Type: article
Abstract: As the application of mass spectrometry intensifies in scope and diversity, the need for advanced instrumentation addressing a wide variety of analytical needs also increases. To this end, many modern, top-end mass spectrometers are designed or modified to include a wider range of fragmentation technologies, for example, ECD, ETD, EThcD, and UVPD. Still, the majority of instrument platforms are limited to more conventional methods, such as CID and HCD. While these latter methods have performed well, the less conventional fragmentation methods have been shown to lead to increased information in many applications including middle-down proteomics, top-down proteomics, glycoproteomics, and disulfide bond mapping. We describe the modification of the popular Q Exactive Orbitrap mass spectrometer to extend its fragmentation capabilities to include ECD. We show that this modification allows ≥85% matched ion intensity to originate from ECD fragment ion types as well as provides high sequence coverage (≥60%) of intact proteins and high fragment identification rates with ∼70% of ion signals matched. Finally, the ECD implementation promotes selective disulfide bond dissociation, facilitating the identification of disulfide-linked peptide conjugates. Collectively, this modification extends the capabilities of the Q Exactive Orbitrap mass spectrometer to a range of new applications.
Source: Journal of Proteome Research
Language: English
Subfield: Spectroscopy
Field: Chemistry
Domain: Physical Sciences
Open Access status: hybrid
Estimated APC paid: $4,500
Funders: European Commission, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Novo Nordisk, Novo Nordisk Fonden, National Institutes of Health, Forsknings- og Innovationsstyrelsen, Danish Agency for Science and Higher Education, National Institute of General Medical Sciences, H2020 Future and Emerging Technologies
Awards: G1076064052, Practical Mass Spectrometer Upgrade for Identifying Fragile Protein Modifications by ECD, G1600759607, Mass spectrometric technology for next generation proteomics in systems medicine, G4282887365, G4283601586, Mass spectrometric technology for next generation proteomics in systems medicine
OpenAlex ID: W2777900905
